2024-10-07 - Analysis Report
## Estee Lauder Companies Inc (EL) Stock Analysis

**Company Overview:** Estee Lauder Companies Inc. is a global manufacturer and marketer of prestige beauty products.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** EL: 15.52%, VOO: 133.14%
* **Lag vs. S&P 500:** -117.62% (Relative Lag: 75%)
* **Interpretation:**  EL has significantly underperformed the S&P 500 over the period analyzed.  It currently lags the benchmark by 75% of its historical range. 

**2. Recent Price Movements:**

* **Closing Price:** $95.86
* **5-day Moving Average:** $97.06
* **20-day Moving Average:** $90.83
* **60-day Moving Average:** $93.59
* **Interpretation:** The stock is currently trading above its 20-day and 60-day moving averages, suggesting some short-term strength. However, it's below the 5-day moving average, indicating recent downward pressure.

**3. Technical Indicators:**

* **RSI:** 68.17 (Overbought)
* **PPO:** 1.04 (Bullish)
* **Delta_Previous_Relative_Divergence:** -3.37 (Short-term Downward Trend)
* **Expected Return:** 0.0% (5-year expected return over S&P 500)
* **Interpretation:** The RSI suggests the stock is currently overbought, potentially indicating a short-term pullback. The PPO indicates a bullish sentiment. The negative relative divergence suggests a possible short-term downward trend. The expected return of 0% suggests that, based on historical performance, EL is not projected to outperform the S&P 500 over the next five years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-05-01 | 0.92 | 3.94 B$ |
| 2024-02-05 | 0.87 | 4.28 B$ |
| 2023-11-01 | 0.09 | 3.52 B$ |
| 2023-05-03 | 0.44 | 3.75 B$ |
| 2024-05-01 | 0.44 | 3.75 B$ |

* **Interpretation:** Estee Lauder has shown mixed earnings performance in recent quarters. The latest earnings report for Q1 2024 (ending May 2024) showed an EPS of $0.92, exceeding analysts' expectations.  Revenue also surpassed estimates, coming in at $3.94 billion. Despite this positive showing, the company's performance in previous quarters has been volatile. 

**5. News and Recent Issues:**

* **Recent Market Outlook:**  Estee Lauder's stock is currently facing challenges due to several factors including:
    * **Economic uncertainty:** The global economy is facing headwinds from inflation and potential recessions.
    * **Luxury goods slowdown:** Consumer spending on luxury goods, including cosmetics, may be impacted by economic uncertainty.
    * **Competitive landscape:**  Estee Lauder faces stiff competition from other beauty giants.
* **Analyst Opinions:**  Analysts remain divided on EL's stock outlook. Some are optimistic about the long-term potential, citing the company's strong brands and global reach. Others are more cautious, citing the headwinds mentioned above.
* **Performance Highlights:** While Estee Lauder has faced challenges, the company continues to invest in innovation and digital transformation, aiming to drive future growth.

**6. Overall Analysis:**

Estee Lauder Companies Inc (EL) is currently lagging the S&P 500 and shows mixed recent performance. While the latest earnings report exceeded expectations, the overall outlook for the company remains uncertain. Technical indicators suggest short-term downward pressure, and the expected return over the S&P 500 is currently 0%. Investors should closely monitor economic conditions and the company's performance to assess potential future growth.

**7. Final Recommendations:**

* **Short-term:** EL is currently trading above its 20-day and 60-day moving averages, suggesting some short-term strength. However, the RSI and relative divergence indicate potential for a short-term pullback.
* **Long-term:**  EL's long-term performance is tied to the health of the luxury goods market and the company's ability to adapt to changing consumer preferences. Investors should consider the company's long-term growth strategy and their own risk tolerance before making any investment decisions. 
